66012-26-8Relevant articles and documents
PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS AS diAGNOSTIC AND RAdiONUCLIDE THERAPEUTIC AGENTS
-
Paragraph 0101; 0120-0121; 0136-0137, (2020/11/03)
The present disclosure relates to compounds according to Formula I. These compounds display very good binding affinities to the PSMA binding sites. They comprise a radioactive isotope or a chelating moiety that can be labeled with a radioactive metal such as [68Ga]or [177Lu]. The present disclosure also relates to pharmaceutical compositions comprising a pharmaceutical acceptable carrier and a compound of Formula I or a complex thereof, or a pharmaceutically acceptable salt thereof.
Processes for forming amide bonds and compositions related thereto
-
Page/Page column 29; 30, (2015/01/07)
The disclosure relates to methods for producing amide bonds and reagents related thereto. In some embodiments, the disclosure relates to methods of producing an amide comprising mixing an O-silylated thionoester and an amine under conditions such that an amide is formed. In another embodiment, the disclosure relates to mixing a thiolacid, a silylating agent, and an amine under conditions such that an amide is formed.
Application of an organophosphorus reagent depbt for synthesis of cycloheptapeptide
Xie,Tian,Ye
, p. 4233 - 4240 (2007/10/03)
A cycloheptapeptide cyclo(Gly-Tyr-Gly-Gly-Pro-Phe-Pro), which was isolated and identified from one kind of Chinese medicinal herbs, was chosen as a model cyclopeptide, to evaluate an organophosphorus reagent, 3-(diethyloxyphosphoryloxy)-1,2,3-benzotriazin